Literature DB >> 22335904

[Effect of quercetin on heat shock protein expression in HepG2 cells determined by SILAC].

Jin Zhou1, Li Fang, Wen-xiu Yao, Xin Zhao, Yang Wei, Hang Zhou, Hua Xie, Li-yang Wang, Li-juan Chen.   

Abstract

OBJECTIVE: To detect the changes of heat shock protein(HSP) expression in human hepatocellular carcinoma HepG2 cells after treated by quercetin through a proteomics strategy termed SILAC (stable isotope labeling by amino acids in cell culture)-MS (mass spectrometry).
METHODS: HepG2 cells cultured in d3-labeled DMEM medium were passaged for more than ten generations to reach an enough high labeling ratio. MTT assay was used to assess the inhibitory effect of quercetin on proliferation of HepG2 cells. In SILAC, total protein was extracted from control HepG2 cells and those treated by 50 µmol/L quercetin for 48 h, and then mixed to a 1:1 ratio. After in-gel digestion and idenfication by LC-MS/MS analysis, quantification informations of changed proteins were acquired by searching on Mascot 2.0 program (MatrixScience Ltd., London) against SWISS-PROT protein database. To ensure a high confidence level for identification, those peptides with Mascot scores below the threshold value were excluded from analysis and not included in the list of quantified proteins (P < 0.01). Protein abundance was calculated as ratios of the peak intensity of the fragment ions from the labeled versus the unlabeled peptides. RT-PCR was uesd to verify the reliability of HSPs changes by quercetin treatment from the SILAC-MS results.
RESULTS: After passaged for ten generations, the d3-labeling ratio was above 95%. MTT showed that quercetin inhibited the proliferation of HepG2 cells obviously, with a IC(50) close to 50 µmol/L, and in a dose-dependent and time-dependent manner. The MS showed that the expression of almost all heat shock family proteins was down-regulated a lot. The expression of HSP90 exposed to quercetin for 48 h was decreased to 49.3% of the normal HepG2 cells, and the expression of HSP70 was decreased to 43.6% of the normal Hep G2 cells. Quantitation information showed that the expression of HSP90α, HSP76, HSP60 and HSP27 was declined to 59.3%, 44.2%, 51.3% and 62.6%, respectively. Those results demonstrated that the quantification for changed protiens by SILAC-MS was correct.
CONCLUSIONS: Quercetin can exert a significant inhibitory effect on whole expression of heat shock proteins in HepG2 cells. We suppose this maybe one of the pathways through which quercetin plays an important anti-tumor role. SILAC-MS is a reliale technique and can be used to quantify the changes of whole protein spectrum in HepG2 cells before and after treatment with some exogeneous factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22335904

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  3 in total

Review 1.  Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma.

Authors:  Chen-Yi Liao; Ching-Chang Lee; Chi-chang Tsai; Chao-Wen Hsueh; Chih-Chiang Wang; I-Hung Chen; Ming-Kai Tsai; Mei-Yu Liu; An-Tie Hsieh; Kuan-Jen Su; Hau-Ming Wu; Shih-Chung Huang; Yi-Chen Wang; Chien-Yao Wang; Shu-Fang Huang; Yen-Cheng Yeh; Ren-Jy Ben; Shang-Tao Chien; Chin-Wen Hsu; Wu-Hsien Kuo
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

Review 2.  Application of Quercetin in the Treatment of Gastrointestinal Cancers.

Authors:  Seyed Mohammad Ali Mirazimi; Fatemeh Dashti; Mohammad Tobeiha; Ali Shahini; Raha Jafari; Mehrad Khoddami; Amir Hossein Sheida; Parastoo EsnaAshari; Amir Hossein Aflatoonian; Fateme Elikaii; Melika Sadat Zakeri; Michael R Hamblin; Mohammad Aghajani; Minoodokht Bavarsadkarimi; Hamed Mirzaei
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

3.  Anticancer and apoptosis‑inducing effects of quercetin in vitro and in vivo.

Authors:  Mahmoud Hashemzaei; Amin Delarami Far; Arezoo Yari; Reza Entezari Heravi; Kaveh Tabrizian; Seyed Mohammad Taghdisi; Sarvenaz Ekhtiari Sadegh; Konstantinos Tsarouhas; Dimitrios Kouretas; George Tzanakakis; Dragana Nikitovic; Nikita Yurevich Anisimov; Demetrios A Spandidos; Aristides M Tsatsakis; Ramin Rezaee
Journal:  Oncol Rep       Date:  2017-06-28       Impact factor: 3.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.